Kenvue Inc. (NYSE:KVUE) Shares Acquired by Eubel Brady & Suttman Asset Management Inc.

Eubel Brady & Suttman Asset Management Inc. increased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 961,138 shares of the company’s stock after acquiring an additional 4,086 shares during the quarter. Kenvue comprises 2.7% of Eubel Brady & Suttman Asset Management Inc.’s investment portfolio, making the stock its 13th biggest position. Eubel Brady & Suttman Asset Management Inc.’s holdings in Kenvue were worth $20,520,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. AMF Tjanstepension AB boosted its stake in Kenvue by 187.3% during the third quarter. AMF Tjanstepension AB now owns 120,477 shares of the company’s stock worth $2,787,000 after buying an additional 78,540 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Kenvue by 6.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,690 shares of the company’s stock worth $571,000 after acquiring an additional 1,449 shares during the period. Signaturefd LLC boosted its position in shares of Kenvue by 394.0% during the 3rd quarter. Signaturefd LLC now owns 4,061 shares of the company’s stock valued at $94,000 after acquiring an additional 3,239 shares during the last quarter. Commerzbank Aktiengesellschaft FI purchased a new stake in shares of Kenvue in the third quarter valued at about $292,000. Finally, International Assets Investment Management LLC increased its position in Kenvue by 1,529.5% during the third quarter. International Assets Investment Management LLC now owns 106,341 shares of the company’s stock worth $2,460,000 after purchasing an additional 99,815 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of several recent analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and issued a $24.00 target price on shares of Kenvue in a report on Monday, February 3rd. UBS Group decreased their price objective on Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, February 7th. Barclays cut their target price on Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Piper Sandler raised Kenvue from a “neutral” rating to an “overweight” rating and upped their price target for the company from $21.00 to $26.00 in a research note on Monday, January 6th. Finally, Canaccord Genuity Group lowered their price target on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a report on Friday, February 7th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $23.00.

Kenvue Stock Performance

NYSE KVUE opened at $23.31 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a market cap of $44.68 billion, a P/E ratio of 43.97, a P/E/G ratio of 2.61 and a beta of 1.45. The stock has a 50-day moving average of $21.29 and a two-hundred day moving average of $22.14. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be paid a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.52%. The ex-dividend date is Wednesday, February 12th. Kenvue’s payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.